PNC-28
PNC-28
PNC-28 is a synthetic peptide derived from a mitochondrial targeting sequence of p53, designed to selectively induce apoptosis in cancerous cells. This peptide functions by disrupting mitochondrial membranes in malignant cells while sparing healthy tissues, making it a promising research tool for studies focused on cancer biology and targeted peptide therapeutics.
PNC-28 plays an important role in modulating pathways of apoptosis and cellular stress response, with demonstrated activity against various tumor cell lines. It has shown potential in reducing tumor growth, enhancing cellular clearance mechanisms, and restoring balance to tissue environments compromised by malignant transformation.
In addition to its antitumor effects, PNC-28 may contribute to improved immune recognition of abnormal cells and support systemic resilience against cancer progression. PNC-28 offers a valuable compound for exploring therapeutic strategies related to oncology, apoptosis regulation, and cancer peptide research.
- Estimated Delivery : Up to 3 business days
- Free Shipping & Returns : On all orders over $300
This peptide comes with alcohol wipes, injection, reconstitution instructions and sterile syringes. Injections are typically subcutaneous in the abdomen, thigh, or upper arm. Follow all included instructions and store the syringes in the refrigerator until use.
Pricing reflects one 20 mg vial. Product usage varies. Some individuals may require more than one vial per month.
All peptide sales are non‑refundable and non‑returnable. However, your satisfaction is important to us — if there is any problem with your order, please contact us right away and we will work with you to make it right.
Peptide therapies are for research wellness support only and are not intended to diagnose, treat, cure, or prevent any disease.
Be the first to review “PNC-28”
Related products
-
NAD+ 500 mg
$177 -
GLP3-Reta
Price range: $114.99 through $199.99 -
SLU-PP-332 5mg
$159.99 -
FOXO4-DRI
$560 -
GLOW
$178
Reviews
There are no reviews yet.